Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

Business Leaders

Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesBusiness LeadersFinance Pro.CalendarSectors 
HomeAll NewsMost read newsBusiness Leaders Biography
Summary 
Charles Elliott Sigal is Member-Drug Discovery & Development Forum at Institute of Medicine, Member-President Council at The J. David Gladstone Institutes and Manager of Segal Family Investments LLC and on the board of 8 other companies.

In the past he held the position of Director, Chief Scientific Officer & Executive VP at Bristol Myers Squibb Co. and President & Chief Executive Officer at Mercator Genetics, Inc.

Dr. Sigal received a doctorate from The University of Chicago and a doctorate, an undergraduate degree and a graduate degree from Purdue University.


Current positions of Charles Elliott Sigal 
NameTitle Since
Vir Biotechnology, Inc.
(Biotechnology & Medical Research)
Independent Director 2020
Adaptimmune Therapeutics plc
(Biotechnology & Medical Research)
Independent Non-Executive Director 2015
Surface Oncology, Inc.
(Biotechnology & Medical Research)
Independent Non-Executive Director 2018
Medarex, Inc. Director -
University Medical Center Trustee -
Melanoma Research Alliance Director 2013
Affinia Therapeutics, Inc. Director 2020
Tessera Therapeutics, Inc. Director 2021
Institute of Medicine Member-Drug Discovery & Development Forum -
The J. David Gladstone Institutes Member-President Council -
Segal Family Investments LLC Manager -


Holdings of Charles Elliott Sigal 
NameEquities%Valuation
Adaptimmune Therapeutics Plc367,0380.065%316,328 USD
Surface Oncology, Inc. (SURF)
(Biotechnology & Medical Research)
45,4530.10%287,717 USD
Vir Biotechnology, Inc. (VIR)
(Biotechnology & Medical Research)
3,3740.0026%173,896 USD


Charles Elliott Sigal: Personal Network 
Most Read News 
09/14BRAD SMITH : Microsoft to buy back up to $60 billion in shares; names Brad Smith vice chair
RE
09/09FRANCESCO GAETANO CALTAGIRONE : Italy's Caltagirone ups Generali stake to just over 6%
RE
09/14CATHIE WOOD : ARK Invest's Wood expects market rotation back to growth stocks
RE
09/13MARTIN SORRELL : Sorrell's S4 Capital raises annual profit outlook for a third time
RE
09/09ELON MUSK : Tesla's Musk asks staff to 'go super hardcore' to ensure decent Q3 delivery number
RE
09/08ELON MUSK : Amazon.com goes for jugular in FCC spat with SpaceX's Musk
RE
03:58pWILLIAM ACKMAN : Ackman's Pershing Square fund surges as Universal soars in stock debut
RE
09/08BILL GATES : Bill Gates' investment firm to take control of Four Seasons in $2.21 billion deal
RE
09/21JEFF BEZOS : UK's Johnson discussed taxation with Amazon's Bezos
RE
09/17STELIOS HAJI-IOANNOU : EasyJet shareholder Stelios Haji-Ioannou shuns rights issue -source
RE
More news


© 2021 People and Ownership :   
Charles Elliott Sigal : Connections